TUDOR INVESTMENT CORP ET AL - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 182 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$433,000
-35.9%
8,626
-48.9%
0.01%
-50.0%
Q2 2022$676,000
+31.0%
16,883
+22.0%
0.02%
+50.0%
Q1 2022$516,000
+27.4%
13,842
+36.1%
0.01%
+71.4%
Q4 2021$405,000
-90.5%
10,173
-91.1%
0.01%
-89.9%
Q3 2021$4,276,000
+12.1%
114,907
+27.3%
0.07%
-4.2%
Q2 2021$3,814,000
+116.8%
90,241
+142.9%
0.07%
+105.7%
Q1 2021$1,759,000
+48.2%
37,154
+91.0%
0.04%
+2.9%
Q4 2020$1,187,000
+336.4%
19,457
+142.1%
0.03%
+277.8%
Q3 2019$272,000
-31.8%
8,037
-24.3%
0.01%
-47.1%
Q1 2019$399,000
-39.9%
10,612
-45.2%
0.02%
+30.8%
Q4 2018$664,000
+28.4%
19,350
+75.9%
0.01%0.0%
Q3 2018$517,000
+14.6%
10,998
-59.3%
0.01%
+18.2%
Q4 2017$451,000
+16.8%
27,031
+40.3%
0.01%
+10.0%
Q3 2017$386,000
-5.9%
19,270
-53.8%
0.01%
-23.1%
Q1 2017$410,000
+454.1%
41,670
+296.9%
0.01%
+550.0%
Q2 2016$74,000
-86.2%
10,500
-87.4%
0.00%
-85.7%
Q1 2016$537,000
+113.9%
83,427
+787.5%
0.01%
+75.0%
Q3 2015$251,000
-46.8%
9,400
-4.1%
0.01%
-42.9%
Q2 2015$472,000
+133.7%
9,800
+195.7%
0.01%
+133.3%
Q1 2015$202,000
-56.1%
3,314
-62.7%
0.01%
-62.5%
Q4 2014$460,000
+122.2%
8,877
+88.4%
0.02%
+128.6%
Q3 2014$207,0004,7110.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders